Journal
IUBMB LIFE
Volume 66, Issue 6, Pages 387-395Publisher
WILEY
DOI: 10.1002/iub.1282
Keywords
human molecular disease; protein function; signal transduction
Categories
Funding
- NIH [U54 CA149147, R01 CA63366, P50 CA083638, CA06927]
- PKD Foundation
Ask authors/readers for more resources
The CAS family of scaffolding proteins has increasingly attracted scrutiny as important for regulation of cancer-associated signaling. BCAR1 (also known as p130Cas), NEDD9 (HEF1, Cas-L), EFS (Sin), and CASS4 (HEPL) are regulated by and mediate cell attachment, growth factor, and chemokine signaling. Altered expression and activity of CAS proteins are now known to promote metastasis and drug resistance in cancer, influence normal development, and contribute to the pathogenesis of heart and pulmonary disease. In this article, we provide an update on recently published studies describing signals regulating and regulated by CAS proteins, and evidence for biological activity of CAS proteins in normal development, cancer, and other pathological conditions. (C) 2014 IUBMB Life, 66(6): 387-395, 2014
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available